We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+4.43%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$28M
AUM Growth
–
Cap. Flow
+$24.6B
Cap. Flow
% of AUM
87,776.56%
Top 10 Holdings %
Top 10 Hldgs %
23.99%
Holding
730
New
730
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$1.86B |
| 2 |
Intel
INTC
|
+$848M |
| 3 |
Corning
GLW
|
+$790M |
| 4 |
GM.PRB
GENERAL MTRS CO JR PFD CONV SER B (DE)
GM.PRB
|
+$787M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$643M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.89% |
| 2 | Healthcare | 11.46% |
| 3 | Financials | 11.14% |
| 4 | Industrials | 7.07% |
| 5 | Consumer Discretionary | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HSNI
426
DELISTED
HSN, Inc.
HSNI
| $10.6K | 0.04% |
+197,001
| New | +$10.7M |
|
|
JOSB
427
DELISTED
JOS A BANK CLOTHIERS INC
JOSB
| $10.5K | 0.04% |
+254,672
| New | +$10.9M |
|
|
AEGR
428
DELISTED
Aegerion Pharmaceuticals
AEGR
| $10.5K | 0.04% |
+165,426
| New | +$8.78M |
|
|
CORE
429
DELISTED
Core Mark Holding Co., Inc.
CORE
| $10.3K | 0.04% |
+649,092
| New | +$9.16M |
|
430
CVB Financial
CVBF
$3.99B
| $10.3K | 0.04% |
+871,920
| New | +$9.72M |
|
431
Casey's General Stores
CASY
$30.5B
| $10.3K | 0.04% |
+170,382
| New | +$10.1M |
|
432
Core Laboratories
CLB
$514M
| $10.2K | 0.04% |
+67,540
| New | +$9.57M |
|
|
AIV
433
Aimco
AIV
$381M
| $10.2K | 0.04% |
+2,555,842
| New | +$10.5M |
|
434
Altria Group
MO
$114B
| $10.1K | 0.04% |
+289,755
| New | +$10.4M |
|
|
SNCR
435
DELISTED
Synchronoss Technologies
SNCR
| $10.1K | 0.04% |
+36,254
| New | +$9.75M |
|
436
Methode Electronics
MEI
$580M
| $10K | 0.04% |
+588,820
| New | +$8.58M |
|
437
ICU Medical
ICUI
$4.69B
| $9.93K | 0.04% |
+137,858
| New | +$9.12M |
|
|
DFT
438
DELISTED
DuPont Fabros Technology Inc.
DFT
| $9.81K | 0.04% |
+406,200
| New | +$10.2M |
|
|
SFE
439
DELISTED
Safeguard Scientifics, Inc.
SFE
| $9.31K | 0.03% |
+580,006
| New | +$9.22M |
|
|
XLNX
440
DELISTED
Xilinx Inc
XLNX
| $9.3K | 0.03% |
+234,747
| New | +$9.02M |
|
441
Werner Enterprises
WERN
$2.23B
| $9K | 0.03% |
+372,535
| New | +$8.92M |
|
442
RTX Corp
RTX
$299B
| $8.9K | 0.03% |
+152,155
| New | +$8.99M |
|
443
McGrath RentCorp
MGRC
$3.01B
| $8.88K | 0.03% |
+259,963
| New | +$8.23M |
|
444
Darling Ingredients
DAR
$9.42B
| $8.81K | 0.03% |
+471,897
| New | +$8.73M |
|
445
National CineMedia
NCMI
$377M
| $8.68K | 0.03% |
+51,401
| New | +$8.43M |
|
446
Minerals Technologies
MTX
$2.37B
| $8.53K | 0.03% |
+206,268
| New | +$8.53M |
|
447
Titan Machinery
TITN
$456M
| $8.47K | 0.03% |
+431,449
| New | +$9.49M |
|
448
Coherent
COHR
$72.9B
| $8.43K | 0.03% |
+518,208
| New | +$8.5M |
|
449
Cognex
CGNX
$11.6B
| $8.42K | 0.03% |
+745,004
| New | +$7.92M |
|
450
NewMarket
NEU
$8.14B
| $8.3K | 0.03% |
+31,631
| New | +$8.54M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Loomis, Sayles & Company, which disclosed 730 positions worth $28M. Its ten largest holdings account for 24% of the portfolio.
Its largest position is Bank of America Series L: 1,536,520 shares worth $85.3K.
By sector, the portfolio is most concentrated in Technology at 15% of assets, followed by Healthcare and Financials.
- Loomis, Sayles & Company's largest Q2 2013 buy was Bank of America Series L: 1,536,520 shares worth $85.3K.
- Loomis, Sayles & Company's ten largest holdings make up 24% of its $28M portfolio in Q2 2013.
- Loomis, Sayles & Company disclosed 730 positions in Q2 2013, its first 13F filing on record.
Based on Loomis, Sayles & Company's 13F filing for Q2 2013, filed 14 Aug 2013.